Neutropenia Clinical Trials

17 recruiting

Neutropenia Trials at a Glance

33 actively recruiting trials for neutropenia are listed on ClinicalTrialsFinder across 6 cities in 32 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Edmonton, Vancouver, and Boston. Lead sponsors running neutropenia studies include Anhui Provincial Hospital, Beneficência Portuguesa de São Paulo, and Alexandria University.

Browse neutropenia trials by phase

Treatments under study

About Neutropenia Clinical Trials

Looking for clinical trials for Neutropenia? There are currently 17 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neutropenia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neutropenia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 33 trials

Recruiting
Phase 2

the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

Breast CancerNeutropenia (Low White Blood Cell Count)Leucogen+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University94 enrolled1 locationNCT07380646
Recruiting
Phase 1Phase 2

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

NeutropeniaInfectionsWarts+2 more
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled1 locationNCT00967785
Recruiting
Phase 2

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

NeutropeniaHematological Malignancy
West Virginia University55 enrolled1 locationNCT05537896
Recruiting
Phase 3

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

Neutropenia
X4 Pharmaceuticals176 enrolled112 locationsNCT06056297
Recruiting
Phase 2

Luspatercept for Clonal Cytopenias of Uncertain Significance

ThrombocytopeniaNeutropeniaAnemia+2 more
Weill Medical College of Cornell University50 enrolled1 locationNCT06788691
Recruiting

Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.

ChemotherapyCancerChemotherapy-induced Neutropenia+3 more
Pomeranian Medical University Szczecin265 enrolled5 locationsNCT06809101
Recruiting

Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection

Neutropenia
Hebei Medical University Fourth Hospital200 enrolled1 locationNCT07434063
Recruiting
Not Applicable

Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers

Hematologic MalignancyBone PainNeutropenia
Alexandria University88 enrolled1 locationNCT07300735
Recruiting

Investigation of the Genetics of Hematologic Diseases

Diamond-Blackfan AnemiaDyskeratosis CongenitaFanconi Anemia+10 more
St. Jude Children's Research Hospital1,716 enrolled1 locationNCT02720679
Recruiting

Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.

Febrile Neutropenia
Shanxi Bethune Hospital20 enrolled1 locationNCT07204522
Recruiting
Phase 2

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

Primary/Secondary PreventionHigh Risk for Febrile Neutropenia of Chemotherapy RegimensIntermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia
Henan Cancer Hospital1,076 enrolled1 locationNCT07187908
Recruiting
Not Applicable

ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy

Febrile Neutropenia
Case Comprehensive Cancer Center30 enrolled1 locationNCT06657183
Recruiting

Next-Generation-Sequencing Approach to Neutropenic Sepsis

Febrile Neutropenia
Boris Böll400 enrolled6 locationsNCT05815628
Recruiting

Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor

Chemotherapy-induced Neutropenia
Anhui Provincial Hospital318 enrolled2 locationsNCT07096479
Recruiting
Early Phase 1

Serial Blood Count Study

NeutropeniaCongenital NeutropeniaCyclic Neutropenia
University of Washington20 enrolled1 locationNCT07066085
Recruiting

Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform

Myelodysplastic SyndromesShwachman-Diamond SyndromeSDS+24 more
Shwachman-Diamond Syndrome Alliance Inc8,000 enrolled1 locationNCT06999954
Recruiting
Phase 4

Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens

Febrile Neutropenia
Beneficência Portuguesa de São Paulo176 enrolled1 locationNCT06342115
Recruiting

Breath Analysis for the Detection of Invasive Fungal Infections

LeukemiaLeukemia, MyeloidLeukemia, Lymphoblastic+4 more
University of Zurich130 enrolled1 locationNCT06537726
Recruiting
Phase 4

Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients

NeutropeniaCytomegalovirus InfectionsInfection in Solid Organ Transplant Recipients+1 more
Tufts Medical Center25 enrolled1 locationNCT05626530
Recruiting

The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease

Inflammatory Bowel DiseasesNeutropeniaNudt15 Deficiency
National Taiwan University Hospital65 enrolled1 locationNCT06913998